CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
ItalianoMARTELLI, ALBERTO MARIA
Dettaglio
MARTELLI, ALBERTO MARIA
DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE
Docenti di ruolo di Ia fascia
Alberto Maria Martelli.; A.M. Martelli.; Alberto M. Martelli; MARTELLI A.; MARTELLI AM.
Pubblicazioni
Risultati 1 - 20 di 257 (tempo di esecuzione: 0.001 secondi).
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
|---|---|---|---|---|---|---|---|
| 1 | A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. | F. Chiarini; A. Lonetti; G. Teti; E. Orsini; D. Bressanin; A.Cappellini; F. Ricci; P. L. Tazzari;... A. Ognibene; M. Falconi; P. Pagliaro; I. Iacobucci; G. Martinelli; S. Amadori; J.A. McCubrey; A.M. Martelli. | 2012 | ONCOTARGET | 1.01 Articolo in rivista | - | |
| 2 | Aberrant Proliferative and Apoptotic Pathways in Acute Lymphoblastic Leukemia (ALL):Molecular Therapies to Overcome Chemo-Resistance. | A. Tafuri; M. Milella; S. Iacovelli; F. De Cave;C. Gregorj; P. Bergamo; A.Miele; R.Licchetta;M. K...onopleva; J.A. McCubrey; A.M. Martelli; R. Foà; M.T Petrucci; M.R. Ricciardi. | 2011 | InTech | 2.01 Capitolo / saggio in libro | - | |
| 3 | Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. | S.L. Abrams, L.S. Steelman, K. Lertpiriyapong, L. Cocco, S. Ratti, M.Y. Follo, A.M. Martelli, S. ...Candido, M. Libra, R.M. Murata, P.L. Rosalen, G. Montalto, M. Cervello, A. Gizak, D. Rakus, W. Mao, P. Lombardi, J.A. McCubrey. | 2019 | ADVANCES IN BIOLOGICAL REGULATION | 1.01 Articolo in rivista | - | |
| 4 | Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells. | S.M. Akula, S. Candido, M. Libra, S.L. Abrams, L.S. Steelman, K. Lertpiriyapong, G. Ramazzotti, S.... Ratti, M.Y. Follo, A.M. Martelli, R.M. Murata, P.L. Rosalen, B. Bueno-Silva, S. Matias de Alencar, G. Montalto, M. Cervello, A. Gizak, D. Rakus, W. Mao, H.-L. Lin, P. Lombardi, J.A. McCubrey. | 2019 | ADVANCES IN BIOLOGICAL REGULATION | 1.01 Articolo in rivista | - | |
| 5 | Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells | Akula S.M.; Candido S.; Abrams S.L.; Steelman L.S.; Lertpiriyapong K.; Cocco L.; Ramazzotti G.; R...atti S.; Follo M.Y.; Martelli A.M.; Murata R.M.; Rosalen P.L.; Bueno-Silva B.; Matias de Alencar S.; Falasca M.; Montalto G.; Cervello M.; Notarbartolo M.; Gizak A.; Rakus D.; Libra M.; McCubrey J.A. | 2020 | ADVANCES IN BIOLOGICAL REGULATION | 1.01 Articolo in rivista | - | |
| 6 | Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients | Follo M.Y.; Mongiorgi S.; Clissa C.; Paolini S.; Martinelli G.; Martelli A.M.; Fioravanti G.; Man...zoli L.; Finelli C.; Cocco L. | 2012 | LEUKEMIA | 1.01 Articolo in rivista | - | |
| 7 | Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235, against T-cell acute lymphoblastic leukemia. | F. Chiarini; C. Grimaldi; F. Ricci; P. L. Tazzari; C.Evangelisti; A. Ognibene; M.Battistelli; E. ...Falcieri; F. Melchionda; A. Pession; P. Pagliaro; J.A. McCubrey; A.M. Martelli. | 2010 | CANCER RESEARCH | 1.01 Articolo in rivista | - | |
| 8 | Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation. | C Simioni; A Cani; A.M. Martelli; G. Zauli; G. Tabellini; J.A. McCubrey; S. Capitani; L.M. Neri . | 2014 | ONCOTARGET | 1.01 Articolo in rivista | - | |
| 9 | Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia | A. Lonetti; I. Lopes Antunes; F. Chiarini; E. Orsini; F. Buontempo; F. Ricci; P.L. Tazzari; P. Pa...gliaro; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; J.T. Barata; A.M. Martelli. | 2014 | LEUKEMIA | 1.01 Articolo in rivista | - | |
| 10 | Activity of the Selective IκB kinase Inhibitor BMS-345541 against T-Cell Acute Lymphoblastic Leukemia: involvement of FOXO3a | F. Buontempo; F. Chiarini; D. Bressanin; G. Tabellini; F. Melchionda; A. Pession; M. Fini; L.M. N...eri; J.A. McCubrey; A.M. Martelli | 2012 | CELL CYCLE | 1.01 Articolo in rivista | - | |
| 11 | Advances in Targeting Signal Transduction Pathways. | J.A. McCubrey; L.S. Steelman; W.H. Chappell; L. Sun; N.M. Davis; S.L. Abrams; R.A. Franklin; L. C...occo; C. Evangelisti; F. Chiarini; A.M. Martelli; M. Libra; S. Candido; G. Ligresti; G. Malaponte; M.C. Mazzarino; P. Fagone; M. Donia; F. Nicoletti; J. Polesel; R. Talamini; J. Bäsecke; S. Mijatovic; D. Maksimovic-Ivanic; M. Milella; A. Tafuri; J. Dulińska-Litewka; P. Laidler; A. B. D’Assoro; L. Drobot ; K. Umezawa; G. Montalto; M. Cervello; Z. N. Demidenko. | 2012 | ONCOTARGET | 1.01 Articolo in rivista | - | |
| 12 | Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. | Chiarini, F; Lonetti, A; Evangelisti, C; Buontempo, F; Orsini, E; Evangelisti, C; Cappellini, A; ...Neri, LM; McCubrey, Ja; Martelli, AM. | 2016 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 1.01 Articolo in rivista | - | |
| 13 | Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells. | F. Charini, C. Evangelisti, G. Lattanzi, J.A. McCubrey, A.M. Martelli. | 2019 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 1.01 Articolo in rivista | - | |
| 14 | The Akt inhibitor MK-2206 is cytotoxic in hepatocarcinoma cells displaying hyperphosphorylated Akt-1 and synergizes with conventional chemotherapy | C. Simioni; A.M. Martelli; A. Cani; R. Cetin-Atalay; J.A. McCubrey; S. Capitani; L.M. Neri. | 2013 | ONCOTARGET | 1.01 Articolo in rivista | - | |
| 15 | Akt is a therapeutic target in cancer | Steelman L.S.; Stadelman K.M.; Chappell W.H.; Horn S.; Basecke J.; Cervello M.; Nicoletti F.; Lib...ra M.; Stivala F.; Martelli A.M.; McCubrey J.A. | 2008 | EXPERT OPINION ON THERAPEUTIC TARGETS | 1.01 Articolo in rivista | - | |
| 16 | Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy | McCubrey J.A.; Sokolosky M.L.; Lehmann B.D.; Taylor J.R.; Navolanic P.M.; Chappell W.H.; Abrams S....L.; Stadelman K.M.; Wong E.W.; Misaghian N.; Horn S.; Bäsecke J.; Libra M.; Stivala F.; Ligresti G.; Tafuri A.; Milella M.; Zarzycki M.; Dzugaj A.; Chiarini F.; Evangelisti C.; Martelli A.M.; Terrian D.M.; Franklin R.A.; Steelman L.S. | 2008 | Elsevier Ltd. | 2.01 Capitolo / saggio in libro | - | |
| 17 | AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. | Grimaldi C.; Chiarini F.; Tabellini G.; Ricci F.; Tazzari P.L.; Battistelli M.; Falcieri E.; Bort...ul R.; Melchionda F.; Iacobucci I.; Pagliaro P.; Martinelli G.; Pession A.; Barata J.T.; McCubrey J.A.; Martelli A.M. | 2012 | LEUKEMIA | 1.01 Articolo in rivista | - | |
| 18 | Antiapoptotic role of p38 mitogen activated protein kinase in Jurkat T cells and normal human T lymphocytes treated with 8-methoxypsoralen and ultraviolet-A radiation | A. Cappellini; P.L. Tazzari; I. Mantovani; A.M. Billi; C. Tassi; F. Ricci; R. Conte; A.M. Martelli | 2005 | APOPTOSIS | 1.01 Articolo in rivista | - | |
| 19 | Antioxidants in the prevention of UVB-induced keratynocyte apoptosis. | S. Salucci; S. Burattini; D. Curzi; F. Buontempo; A.M. Martelli; G. Zappia; E. Falcieri; M. Batti...stelli. | 2014 | JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY | 1.01 Articolo in rivista | - | |
| 20 | Application of flow cytometry to molecular medicine: Detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts | Cappellini A; Mantovani I; Tazzari PL; Grafone T; Martinelli G; Cocco L; Martelli AM | 2005 | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 1.01 Articolo in rivista | - |
Copyright © 2021